Pharmacokinetics [phsf]
Safety [hcpp]
Olmesartan medoxomil [orch, phsu]
Combination [qlco]
Glibenclamide [orch, phsu]
Healthy Volunteers [popg]
Objective [inpr]
investigate [ftcn]
PHARMACOKINETIC [resa]
Interaction [ftcn]
Safety [hcpp]
TOLERABILITY [resa]
Combination [qlco]
Olmesartan medoxomil [orch, phsu]
Glibenclamide [orch, phsu]
Methods [inpr]
Open [spco]
cross over [genf]
Phase I Trial [resa]
Healthy adult [fndg]
Entered [qlco]
Ordered [qlco]
SEVEN-DAY [inpr]
treatment [ftcn]
Treatments [topp]
Once daily [tmco]
Administration [ocac]
olmesartan [orch, phsu]
mg% [qnco]
olmesartan [orch, phsu]
mg/mg [qnco]
Plus [qlco]
Glibenclamide [orch, phsu]
Glibenclamide [orch, phsu]
mg% [qnco]
Combination [qlco]
olmesartan [orch, phsu]
Glibenclamide [orch, phsu]
Bioequivalence [qlco]
Area [geoa]
plasma concentration [qnco]
Curve [spco]
steady state [npop]
Dose [qnco]
Interval [tmco]
Tau [inpr]
24 hours [tmco]
AUC [qnco]
SS [geoa]
Tau [inpr]
Maximum Concentration [qnco]
steady state [npop]
SS [geoa]
Cmax [qnco]
Substances [sbst]
AUC [qnco]
SS [geoa]
Tau [inpr]
Values [qlco]
olmesartan [orch, phsu]
ng/h/mL [qnco]
olmesartan [orch, phsu]
Alone [qnco]
ng/h/mL [qnco]
Combination [qlco]
Glibenclamide [orch, phsu]
SS [geoa]
Cmax [qnco]
Values [qlco]
Glibenclamide [orch, phsu]
AUC [qnco]
SS [geoa]
Tau [inpr]
Values [qlco]
H+ [elii]
H+ [elii]
Combination [qlco]
olmesartan [orch, phsu]
Reach [orgf]
SS [geoa]
Cmax [qnco]
Tmax [qnco]
Glibenclamide [orch, phsu]
shifted [ftcn]
2 H [elii]
1 H [elii]
Combined [qlco]
olmesartan [orch, phsu]
Tmax [qnco]
Values [qlco]
olmesartan [orch, phsu]
Unchanged [fndg]
H+ [elii]
combined treatment [topp]
olmesartan [orch, phsu]
Plus [qlco]
Glibenclamide [orch, phsu]
Adverse event [fndg]
Occurred [acty]
Medications [phsu]
Well [qlco]
exception [idcn]
Slight [qlco]
Shift [ftcn]
Tmax [qnco]
Values [qlco]
Glibenclamide [orch, phsu]
Concomitant [tmco]
Administration [ocac]
Olmesartan medoxomil [orch, phsu]
Glibenclamide [orch, phsu]
effects [qlco]
steady state [npop]
Pharmacokinetics [phsf]
Agent [chvf]
PHARMACOKINETIC [resa]
Rationale [idcn]
Clinical Studies [resa]
Test [lbpr]
Combination Therapy [topp]
Patients [podg]
Hypertension [dsyn]
Diabetes Mellitus, Type 2 [dsyn]
Compound [qlco]
